Masimo Corporation Market Share Analysis

Publisher Name :
Date:12-Dec-2012
No. of pages: 221
Inquire Before Buying

Masimo Corporation Market Share Analysis

Summary

GlobalData’s new report, “Masimo Corporation Market Share Analysis” provides in-depth information on Masimo Corporation’s market position in the respiratory measurement devices market. The report also provides data and information on the overall competitive landscape within the respiratory measurement devices market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the respiratory measurement devices market.
- Masimo Corporation’s company shares (in Revenues) information for all the key countries the company has presence in -Brazil, Italy, Spain, United Kingdom, Germany, France, China, Japan, India, Australia, United States and Canada.
- Masimo Corporation’s company shares (in Revenues) information for the respiratory measurement devices market.
- All the key data-points are for 2011 and cover all the key regions -Europe, Asia-Pacific, North America, South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Masimo Corporation’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Masimo Corporation’s market positions.

Masimo Corporation Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 7
2.1 What Is This Report About? 7
3 Definitions of Markets/Categories Covered 8
3.1 Anesthesia and Respiratory Devices 8
4 Company Snapshot 9
4.1 Key Facts 9
4.2 Company Overview 9
4.3 Financial Performance 9
4.4 SWOT Snapshot 9
4.5 Business Overview 10
4.6 Major Products and Services 11
5 History 13
6 SWOT Analysis 17
6.1 Overview 17
6.2 Masimo Corporation Strengths 17
6.3 Masimo Corporation Weaknesses 18
6.4 Masimo Corporation Opportunities 19
6.5 Masimo Corporation Threats 20
7 Competitors 21
8 Competitive Landscape 22
8.1 Anesthesia and Respiratory Devices (Respiratory Measurement Device), Global, Market Share (%), 2011 22
8.2 Masimo Corporation., Anesthesia and Respiratory Devices (Respiratory Measurement Devices), by Region, Market Share (2011) 24
8.3 Masimo Corporation, Anesthesia and Respiratory Devices (Respiratory Measurement Devices), by Country, Market Share (2011) 26
9 Key Employees 28
10 Key Employee Biographies 29
11 Company Statement 30
12 Locations And Subsidiaries 33
12.1 Head Office 33
12.2 Other Locations & Subsidiaries 33
13 Financial Deals Landscape 36
13.1 Masimo Corporation, Deals Volume Summary, 2006 to YTD 2012 36
14 Masimo Corporation Detailed Deal Summary 38
14.1 Asset Purchase 38
14.2 Partnerships 39
14.3 Equity Offering 60
14.4 Acquisition 62
15 Recent Developments 66
15.1 Strategy And Business Planning 66
15.2 Financial Announcements 68
15.3 Research And Development 84
15.4 Corporate Communications 88
15.5 Legal and Regulatory 91
15.6 Product News 94
15.7 Product Approvals 164
15.8 Clinical Trials 169
15.9 Other Significant Developments 192
16 Appendix 207
16.1 Research Methodology 208
16.2 Secondary Research 208
16.3 Primary Research 209
16.4 Models 209
16.5 Forecasts 209
16.6 Expert Panels 210
16.7 GlobalData Consulting 210
16.8 Currency Conversion 211
16.9 Contact Us 212
16.10 Disclaimer 212

1.1 List of Tables
Table 1: Masimo Corporation, Key Facts, 2011 18
Table 2: Masimo Corporation, SWOT Analysis, 2011 26
Table 3: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 32
Table 4: Masimo Corporation., Anesthesia and Respiratory Devices (Respiratory Measurement Devices), by Region, Revenue ($m) and Market Share (%), 2011 34
Table 5: Masimo Corporation, Anesthesia and Respiratory Devices (Respiratory Measurement Devices), by Country, Revenue ($m) and Market Share (%), 2011 36
Table 6: Masimo Corporation, Key Employees 37
Table 7: Masimo Corporation, Other Locations 42
Table 8: Masimo Corporation, Subsidiaries 43
Table 9: Masimo Corporation, Deals Volume Summary, 2006 to YTD 2012 45
Table 10: Masimo Corporation, Deals Summary, 2006 to YTD 2012 46
Table 11: SEDLine Acquires SEDLine Brain Function Monitoring Business From Hospira 47
Table 12: Biolight Meditech Enters Into Licensing Agreement With Masimo 48
Table 13: Masimo Signs Licensing Agreement With Royal Fornia Electronic Device 49
Table 14: Fukuda Denshi Enters Into An Agreement With Masimo 50
Table 15: Masimo Enters Into Licensing Agreement With CareFusion 51
Table 16: Masimo Enters Into Licensing Agreement With GS Electro Medical Equipment 52
Table 17: Masimo Enters Into Licensing Agreement With Nihon Kohden 53
Table 18: Masimo Enters Into Licensing Agreement With ZOLL Medical 54
Table 19: Masimo Enters Into Licensing Agreement With Fukuda Denshi 55
Table 20: Zondan Enters Into Technology Integration Agreement With Masimo 56
Table 21: GE Healthcare Enters Into Technology Integration Agreement With Masimo 57
Table 22: Welch Allyn Enters Into Strategic Partnership With Masimo 58
Table 23: Masimo Enters Into Partnership Agreement With Royal Philips 59
Table 24: Newtech Enters Into An Agreement With Masimo 60
Table 25: Welch Allyn Enters Into Strategic Technology Integration Agreement With Masimo 61
Table 26: Masimo Enters Into Distribution Agreement With Oridion Systems 62
Table 27: Masimo Enters Into An Agreement With Oridion Systems 63
Table 28: Masimo Enters Into An Agreement With Schiller 64
Table 29: Welch Allyn Enters Into An Agreement With Masimo 65
Table 30: Atom Medical Enters Into An Agreement With Masimo 66
Table 31: Drager Medical Enters Into An Agreement With Masimo 67
Table 32: Respironics Enters Into An Agreement With Masimo 68
Table 33: Masimo Completes IPO Of $55.89 Million 69
Table 34: Masimo Acquires Phasein, Multigas Analyzers Maker, For $30 Million 71
Table 35: Masimo Completes Acquisition Of SEDLine 73
Table 36: SEDLine Receives Investment Of $3.5 Million From Masimo 74
Table 37: USD to Local Currency, Average Exchange Rate, 2011 220

1.2 List of Figures
Figure 1: Anesthesia and Respiratory Devices (Respiratory Measurement Device), Global, Market Share (%), 2011 31
Figure 2: Masimo Corporation., Anesthesia and Respiratory Devices), by Region, Market Share (%), 2011 33
Figure 3: Masimo Corporation., Anesthesia and Respiratory Devices), by Country, Market Share (%), 2011 35
Figure 4: Masimo Corporation, Deals Volume Summary, 2006 to YTD 2012 45
  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Bangladesh Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 110
    BMI View: We consider Bangladesh's commitment to another round of spending on the development of healthcare, information technology, infrastructure, energy production, education, agriculture and food security and transportation in fiscal year 2014/2015 as a sound investment. While we are optimistic that ongoing tax reform efforts by the government will rake in more revenues to support development spending, and keep the country's budget deficit manageable at around 3.0% of GDP over the coming yea......
  • Central America Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 73
    BMI View: Costa Rica and Panama will continue to outperform other Central American countries, namely El Salvador, Guatemala, Honduras, Nicaragua and Belize. The business-friendly environment, high percapita medicine spending and strong consumer demand still present strong revenue-generating opportunities for multimodal pharmaceutical companies. Headline Expenditure Projections ? Pharmaceuticals: USD3.5bn in 2013 to USD3.7bn in 2014; +4.1%. Our forecast has been revised slightly down since Q314 d......
  • Iran Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 115
    BMI View: BMI continues to adjust its forecasts for Iran's pharmaceutical market to account for the sanction-induced currency crisis and high rates of inflation. The rapid depreciation of the rial means that we expect the value of the market to contract sharply in US dollar terms. While improved international relations have reduced the regulatory risk associated with operating in the market for multinational drugmakers, the recent proclamation of the Islamic State (IS) in neighbouring Iraq and S......
  • Ireland Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 78
    BMI View: The US government and the OECD recent proposals to discourage corporate inversion pose downside risk to the rate of M&A deals that opt to establish their new headquarters' domicile in Ireland, although the megatrend of consolidation within the pharmaceutical industry, including cross-border mergers and redomiciling in Ireland for tax saving purposes, is expected to continue over the near term. More broadly, due to potential acquisitive interest in different Irish pharmaceutical equitie......
  • Kazakhstan Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 93
    BMI View: Kazakhstan's healthcare sector suffers from a lack of trained medical professionals and the inherent difficulties of providing infrastructure and access to healthcare in such a large country. However, the government continues to show its commitment to improving healthcare as it allocates more funds to constructing new health clinics across the country. Although Kazakhstan's growing pharmaceutical industry will be driven by demand for generic medicines over the medium term, we believe t......
  • Myanmar Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 61
    BMI View: While the current medical gap will attract some foreign investors into Myanmar, we highlight that the lack of basic infrastructure and political instability will potentially affect the growth of the economy. Headline Expenditure Projections ? Pharmaceutical sales: MMK324.8bn (USD350mn) in 2013 to MMK387.5bn (USD390mn) in 2014; +19.3% in local currency terms and +11.3% in US dollar terms. Forecast unchanged from previous quarter. ? Healthcare Expenditure: MMK1,047.3bn (USD1.1bn) in 2013......
  • Slovenia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 91
    BMI View: Slovenia is facing deflationary pressures on consumer prices, which will impact pharmaceutical spending - especially as an increasing proportion of high-value drugs is met by co-payments. We have therefore downwardly revised our pharmaceutical forecast for 2014. A high budget deficit limits room for the new government to increase funding for health services, and we expect healthcare spending to decline this year and next, before returning to modest growth in 2016. Headline Expenditure ......
  • United States Pharmaceuticals and Healthcare Report Q4 2014
    Published: 17-Sep-2014        Price: US $1295 Onwards        Pages: 122
    BMI View: The US pharmaceutical market presents strong commercial opportunities across the industry. Total US pharmaceutical sales reached USD347.2bn in 2013 - more than three times the size of its nearest rival Japan. The US boasts the largest individual markets across the three core sub-sectors: patented, generic and over-the-counter medicines. State-level pharmaceutical markets in the country are larger than many country-level pharmaceutical markets. Headline Expenditure Projections ? Pharmac......
  • Tolvaptan – Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
    Published: 16-Sep-2014        Price: US $1400 Onwards        
    Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know."The most extensive source of patent information available." Product Portfolio Manager - Dr Reddys Laboratories"The database is reliable, frequently updated, well-arranged, user friend......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs